Using non-parametric Kruskal–Wallis testing, there were no significant differences between PD manifesting and non-manifesting carriers for LRRK2 G2019S and R1441 hotspot mutation carriers for any of the BMP isoforms (Supplementary Table 4). This evidence concerns the gene LRRK2 and Parkinson disease.